125 related articles for article (PubMed ID: 17132762)
1. Induction of glutathione synthesis explains pharmacodynamics of high-dose busulfan in mice and highlights putative mechanisms of drug interaction.
Bouligand J; Deroussent A; Simonnard N; Opolon P; Morizet J; Connault E; Daudigeos E; Re M; Paci A; Vassal G
Drug Metab Dispos; 2007 Feb; 35(2):306-14. PubMed ID: 17132762
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase activity influences busulfan pharmacokinetics in patients with beta thalassemia major undergoing bone marrow transplantation.
Poonkuzhali B; Chandy M; Srivastava A; Dennison D; Krishnamoorthy R
Drug Metab Dispos; 2001 Mar; 29(3):264-7. PubMed ID: 11181493
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients.
Zwaveling J; Press RR; Bredius RG; van Derstraaten TR; den Hartigh J; Bartelink IH; Boelens JJ; Guchelaar HJ
Ther Drug Monit; 2008 Aug; 30(4):504-10. PubMed ID: 18641537
[TBL] [Abstract][Full Text] [Related]
4. Busulfan conjugation by glutathione S-transferases alpha, mu, and pi.
Czerwinski M; Gibbs JP; Slattery JT
Drug Metab Dispos; 1996 Sep; 24(9):1015-9. PubMed ID: 8886613
[TBL] [Abstract][Full Text] [Related]
5. Different effects of nine clausenamide ennatiomers on liver glutathione biosynthesis and glutathione S-transferase activity in mice.
Wu YQ; Liu LD; Wei HL; Liu GT
Acta Pharmacol Sin; 2006 Aug; 27(8):1024-8. PubMed ID: 16867254
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase conjugation of organophosphorus pesticides yields S-phospho-, S-aryl-, and S-alkylglutathione derivatives.
Fujioka K; Casida JE
Chem Res Toxicol; 2007 Aug; 20(8):1211-7. PubMed ID: 17645302
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation.
Bredschneider M; Klein K; Mürdter TE; Marx C; Eichelbaum M; Nüssler AK; Neuhaus P; Zanger UM; Schwab M
Clin Pharmacol Ther; 2002 Jun; 71(6):479-87. PubMed ID: 12087351
[TBL] [Abstract][Full Text] [Related]
8. Chronopharmacology of high-dose busulfan in children.
Vassal G; Challine D; Koscielny S; Hartmann O; Deroussent A; Boland I; Valteau-Couanet D; Lemerle J; Lévi F; Gouyette A
Cancer Res; 1993 Apr; 53(7):1534-7. PubMed ID: 8453619
[TBL] [Abstract][Full Text] [Related]
9. Glutathione and glutathione-related enzymes in busulfan treated rat lens.
Cherian M; Rawal UM
Indian J Exp Biol; 1991 May; 29(5):452-5. PubMed ID: 1916943
[TBL] [Abstract][Full Text] [Related]
10. Influence of glutathione S-transferase A1 polymorphism on the pharmacokinetics of busulfan.
Kusama M; Kubota T; Matsukura Y; Matsuno K; Ogawa S; Kanda Y; Iga T
Clin Chim Acta; 2006 Jun; 368(1-2):93-8. PubMed ID: 16448639
[TBL] [Abstract][Full Text] [Related]
11. Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage.
Arfsten DP; Johnson EW; Wilfong ER; Jung AE; Bobb AJ
Cutan Ocul Toxicol; 2007; 26(2):113-34. PubMed ID: 17612979
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of four-times-daily versus once-daily intravenous busulfan in conditioning therapy for hematopoietic cell transplantation.
Ryu SG; Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Hur EH; Lee SH; Bae KS; Noh GJ; Lee MS; Yun SC; Han SB; Lee KH
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1095-105. PubMed ID: 17697972
[TBL] [Abstract][Full Text] [Related]
13. Toxicity of high-dose busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation.
Kasai M; Kiyama Y; Watanabe M; Seto K; Matsuura A; Tanaka J; Takeda H; Naohara T; Higa T; Hashino S
Transplant Proc; 1992 Aug; 24(4):1529-30. PubMed ID: 1496647
[No Abstract] [Full Text] [Related]
14. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
Carreras E; Rosiñol L; Terol MJ; Alegre A; de Arriba F; García-Laraña J; Bello JL; García R; León A; Martínez R; Peñarrubia MJ; Poderós C; Ribas P; Ribera JM; San Miguel J; Bladé J; Lahuerta JJ;
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1448-54. PubMed ID: 18022574
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
Madden T; de Lima M; Thapar N; Nguyen J; Roberson S; Couriel D; Pierre B; Shpall EJ; Jones RB; Champlin RE; Andersson BS
Biol Blood Marrow Transplant; 2007 Jan; 13(1):56-64. PubMed ID: 17222753
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation.
Schechter T; Finkelstein Y; Doyle J; Verjee Z; Moretti M; Koren G; Dupuis LL
Biol Blood Marrow Transplant; 2007 Mar; 13(3):307-14. PubMed ID: 17317584
[TBL] [Abstract][Full Text] [Related]
17. Effects of polysaccharide peptides from COV-1 strain of Coriolus versicolor on glutathione and glutathione-related enzymes in the mouse.
Yeung JH; Or PM
Food Chem Toxicol; 2007 Jun; 45(6):953-61. PubMed ID: 17240508
[TBL] [Abstract][Full Text] [Related]
18. Influence of underlying disease on busulfan disposition in pediatric bone marrow transplant recipients: a nonparametric population pharmacokinetic study.
Bertholle-Bonnet V; Bleyzac N; Galambrun C; Mialou V; Bertrand Y; Souillet G; Aulagner G
Ther Drug Monit; 2007 Apr; 29(2):177-84. PubMed ID: 17417071
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.
Gupta E; Olopade OI; Ratain MJ; Mick R; Baker TM; Berezin FK; Benson AB; Dolan ME
Clin Cancer Res; 1995 Oct; 1(10):1133-8. PubMed ID: 9815904
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of glutathione S-transferase A1-1 in ECV 304 cells protects against busulfan mediated G2-arrest and induces tissue factor expression.
Ritter CA; Sperker B; Grube M; Dressel D; Kunert-Keil C; Kroemer HK
Br J Pharmacol; 2002 Dec; 137(7):1100-6. PubMed ID: 12429583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
